Maternal immunisation: Ethical issues

Marcel Verweij*, Philipp Lambach, Justin R. Ortiz, Andreas Reis

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)

Abstract

There has been increased interest in the potential of maternal immunisation to protect maternal, fetal, and infant health. Maternal tetanus vaccination is part of routine antenatal care and immunisation campaigns in many countries, and it has played an important part in the reduction of maternal and neonatal tetanus. Additional vaccines that have been recommended for routine maternal immunisation include those for influenza and pertussis, and other vaccines are being developed. Maternal immunisation is controversial since regulators, professionals, and the public are often reluctant to accept pharmaceutical interventions during pregnancy. So far, little attention has been given to the ethics of vaccination during pregnancy. In this Personal View we argue that maternal immunisation should be offered in response to concrete, severe risks of disease for mother and child, and we explain how this requirement of serious risk can be used to guide ethical decision-making about maternal immunisation.

Original languageEnglish
Pages (from-to)e310-e314
JournalThe Lancet Infectious Diseases
Volume16
Issue number12
DOIs
Publication statusPublished - 2016

Fingerprint Dive into the research topics of 'Maternal immunisation: Ethical issues'. Together they form a unique fingerprint.

Cite this